MEDIFAST (MED)
(Delayed Data from NYSE)
$18.68 USD
-0.31 (-1.63%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $18.69 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Medifast (MED) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$17.25 | $18.00 | $16.50 | -9.16% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Medifast comes to $17.25. The forecasts range from a low of $16.50 to a high of $18.00. The average price target represents a decline of 9.16% from the last closing price of $18.99.
Analyst Price Targets (2 )
Broker Rating
Medifast currently has an average brokerage recommendation (ABR) of 4.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 4.00 a month ago based on two recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/6/2024 | D.A. Davidson | Linda B Weiser | Hold | Strong Sell |
5/1/2024 | Stephens | Jim Salera | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 4.00 |
ABR (Last week) | 4.00 |
# of Recs in ABR | 2 |
Average Target Price | $17.25 |
LT Growth Rate | NA |
Industry | Food - Miscellaneous |
Industry Rank by ABR | 88 of 253 |
Current Quarter EPS Est: | -0.15 |
MED FAQs
MEDIFAST INC (MED) currently has an average brokerage recommendation (ABR) of 4.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for MEDIFAST INC (MED) is $17.25. The current on short-term price targets is based on 2 reports.
The forecasts for MEDIFAST INC (MED) range from a low of $16.5 to a high of $18. The average price target represents a decline of $7.66 from the last closing price of $18.68.
The current DOWNSIDE for MEDIFAST INC (MED) is 7.66%
Based on short-term price targets offered by two analysts, the average price target for Medifast comes to $17.25. The forecasts range from a low of $16.50 to a high of $18.00. The average price target represents a decline of 9.16% from the last closing price of $18.99.